Nonhealing Diabetic Foot Ulcers Treated With Standard of Care (SOC) Alone or Standard of Care and Amnion-Intermediate-Chorion (AIC)

Part of paid clinical trials in Santa Rosa, California.

Sponsor
Cellution Biologics
Study ID
NCT07014176
Phase
PHASE4
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Amnion-Intermediate-Chorion — OTHER
    Dehydrated human placental multilayer allograft from derived donated human tissue. AIC contains amnion and chorion layers as well as basement membrane and trophoblast.
  • Standard of Care (SOC) — PROCEDURE
    Standard of care is to establish a clean, healthy wound bed and optimize the wound environment to have the best chance of healing the wound. This is achieved through wound cleansing, debridement, offloading and moisture balance.

Study Details

The purpose of this study is to determine how well our dHPT (Dehydrated Human Placental Tissue) Product and Standard of Care work when compared to Standard of Care alone in achieving complete closure of diabetic foot.

Key Dates

Start date
Jul 3, 2025
Status verified
Oct 2025
Primary completion
Jun 30, 2026
Completion
Oct 31, 2026

Study Design

Enrollment
120 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Standard of Care
    Beginning at the screening visit, participants will receive weekly treatment with standard of care (cleaning, debridement, ulcer moisture balance, and offloading) until ulcer closure, or a maximum of 12 weeks, whichever occurs first.
  • Experimental: AIC and Standard of Care
    Participants with a diabetic foot ulcer (DFU) will receive treatment with an Amnion-Intermediate-Chorion (AIC) sheet product, a dehydrated multilayer human placental tissue derived from donated human tissue, and weekly treatment with standard of care (cleaning, debridement, ulcer moisture balance, and offloading) until ulcer closure, or a maximum of 12 weeks, whichever occurs first.

Primary Outcome Measure

Percentage of ulcers with complete wound closure [ Time Frame: 1-12 weeks ]

Central Contacts

Locations (8)

FacilityCityStateZIPSite coordinators
005Santa RosaCalifornia95403
Coordinator
7075443338
001JacksonvilleFlorida32216
Coordinator
9047311711
003ChicagoIllinois60611
Coordinator
810-275-1900
Sayeed, MD (PRINCIPAL_INVESTIGATOR)
007MooresvilleNorth Carolina28117
Coordinator
(704) 662-8336
002Rocky MountNorth Carolina27804
Coordinator
252-443-7114
008AllentownPennsylvania18104
Coordinator
610-330-9740
004PhiladelphiaPennsylvania19146
Coordinator
9047311711
006Hilton Head IslandSouth Carolina29926-

Find similar trials in Santa Rosa, CA

Related Studies